meglumine has been researched along with gadoxetic acid disodium in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (3.80) | 18.2507 |
2000's | 10 (12.66) | 29.6817 |
2010's | 55 (69.62) | 24.3611 |
2020's | 11 (13.92) | 2.80 |
Authors | Studies |
---|---|
Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
Giovagnoni, A; Paci, E | 1 |
Anelli, PL; Cupelli, F; Lorusso, V; Pascolo, L; Tiribelli, C; Uggeri, F; Visigalli, M | 1 |
Helmberger, T; Semelka, RC | 1 |
Reimer, P; Schima, W; Schneider, G | 1 |
Gaffke, G; Gnauck, M; Lopez-Häninnen, E; Streitparth, F; Stroszczynski, C; Wieners, G | 1 |
Ward, J | 1 |
Albiin, N; Brismar, TB; Dahlström, N; Persson, A; Smedby, O | 1 |
Guarise, A; Morana, G; Salviato, E | 1 |
Brancatelli, G; Catalano, C; Federle, MP; Lagalla, R; Marin, D; Midiri, M; Passariello, R; Vilgrain, V | 1 |
Inoue, Y; Izawa, K; Kiryu, S; Ohtomo, K; Shimada, M; Tojo, A; Watanabe, M; Yoshikawa, K | 1 |
Albiin, N; Brismar, TB; Dahlstrom, N; Edsborg, N; Persson, A; Smedby, O | 1 |
Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK | 1 |
Blakeborough, A; Breuer, J; Filippone, A; Grazioli, L; Gschwend, S; Hammerstingl, R; Heinz-Peer, G; Huppertz, A; Kittner, T; Laghi, A; Leen, E; Lencioni, R; Lucidarme, O; Remplik, P; Robinson, PJ; Ruehm, SG; Schaefer, F; Stoupis, C; Tombach, B; Valette, PJ; Zech, CJ | 1 |
Essig, M; Giesel, FL; Mehndiratta, A | 1 |
Hussain, S; Karam, AR; Kim, YH; Shankar, S; Surapaneni, P | 1 |
Pastor, CM | 1 |
Choi, BI; Han, JK; Kim, SH; Lee, JM; Lee, JY; Lee, MS; Park, HS | 1 |
Fidler, J; Hough, D | 1 |
Boll, DT; Feuerlein, S; Gupta, RT; Merkle, EM | 1 |
D'Souza, SL; Frydrychowicz, A; Nagle, SK; Reeder, SB; Vigen, KK | 1 |
Brown, JJ; Fowler, KJ; Narra, VR | 1 |
Brismar, TB; Dahlqvist Leinhard, O; Dahlström, N; Kihlberg, J; Lundberg, P; Sandström, P; Smedby, O | 1 |
Dobson, JE; Goodwin, MD; Lim, BG; Sirlin, CB; Stella, DL | 1 |
Boll, DT; Davis, DE; Feuerlein, S; Gupta, RT; Husarik, DB; Marin, D; Merkle, EM | 1 |
Brown, JJ; Frydrychowicz, A; Lubner, MG; Merkle, EM; Nagle, SK; Reeder, SB; Rofsky, NM | 1 |
Chen, SH; Chiu, YY; Hsieh, TJ; Hsu, JS; Jaw, TS; Kuo, YT; Liu, GC; Tsai, KB; Wang, YM | 1 |
Gupta, RT; Iseman, CM; Leyendecker, JR; Merkle, EM; Shyknevsky, I; Taouli, B | 1 |
Koh, DM | 1 |
de Campos, RO; Hernandes, M; Kim, BS; Kim, HJ; Kim, MJ; Kim, SH; Semelka, RC | 1 |
Colagrande, S; Lucarini, S; Pradella, S | 1 |
Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
Bashir, MR; Boll, DT; Gupta, RT; Husarik, DB; Merkle, EM; Ringe, KI | 1 |
Byun, JH; Kim, HJ; Kim, N; Kim, PN; Park, SH; Shin, YM; Yeom, SK | 1 |
Angthong, W; Gerber, DA; Hayashi, PH; Kim, BS; Peacock, J; Ranatunga, A; Semelka, RC; Srirattanapong, S; Woosley, JT | 1 |
Agarwal, S; Brunt, EM; Fowler, KJ; Menias, CO; Narra, VR; Shetty, AS | 1 |
Besa, C; Cooper, N; Donnerhack, C; Dyvorne, H; Facciuto, M; Kakite, S; Taouli, B | 1 |
Koh, DM; Riddell, AM; Thian, YL | 1 |
Bashir, MR; Burke, LM; Jaffe, TA; Marin, D; Pietryga, JA | 1 |
Arimura, H; Hayashida, E; Oda, S; Okigawa, T; Okumura, S; Sasao, A; Tajiri, S; Urata, J; Utsunomiya, D; Wada, H; Yamashita, Y | 1 |
Colagrande, S; Grazioli, L; Laghi, A; Morana, G; Paolantonio, P; Ragozzino, A; Vanzulli, A | 1 |
Andreisek, G; Boss, A; Chuck, NC; Curcio, R; Froehlich, JM; Goetschi, S; Nanz, D; Runge, VM | 1 |
Bashir, MR; Castelli, P; Davenport, MS; Hussain, HK; Jaffe, TA; Larson, D; Marin, D | 1 |
Budjan, J; Haneder, S; Michaely, HJ; Morelli, JN; Ong, M; Riffel, P; Schoenberg, SO | 1 |
Abujudeh, HH; Aran, S; Shaqdan, KW | 1 |
Bannas, P; Bookwalter, CA; Motosugi, U; Reeder, SB; Sano, K | 1 |
Bolondi, L; Colombo, M; Forzenigo, LV; Galassi, M; Golfieri, R; Granito, A; Iavarone, M; Piscaglia, F; Renzulli, M; Salvatore, V; Sangiovanni, A; Vavassori, S | 1 |
Kay, J; Todd, DJ | 1 |
Besa, C; Chatterji, M; Facciuto, M; Jajamovich, G; Lewis, S; Taouli, B; Vasudevan, P | 1 |
Brancatelli, G; Cabibbo, G; Dioguardi Burgio, M; Lagalla, R; Midiri, M; Picone, D | 1 |
Cameron, AL; Duncan, JK; Ma, N; Maddern, G; Vreugdenburg, TD | 1 |
Allen, BC; Bashir, MR; Jaffe, TA; McClellan, TR; Middleton, MS; Miller, CM; Motosugi, U; Reeder, SB; Sirlin, CB | 1 |
Borhani, AA; Close, ON; Furlan, A; Heller, MT; Wu, YH | 1 |
Chen, BY; Coughlin, DD; Dupuis, CS; Karam, AR; Scortegagna, E | 1 |
Akata, D; Karcaaltincaba, M; Ünal, E | 1 |
Elizalde-González, MP; García-Díaz, E; González-Perea, M; Mattusch, J | 1 |
Adam, G; Bannas, P; Henes, FO; Rausch, VH; Well, L | 1 |
Chang, SD; Harris, AC; Scali, EP; Tiwari, HA; Walshe, T | 1 |
Glockner, JF; Lee, CU; Mounajjed, T | 1 |
Bruno, O; Ciolina, M; Di Martino, M; Pommier, R; Ronot, M; Vilgrain, V | 1 |
Miller, FH; Mozaffary, A; Schmitz, B; Sodagari, F; Wood, CG; Yaghmai, V | 1 |
Allen, BC; Bashir, MR; Ho, LM; Jaffe, TA; Mazurowski, MA; Miller, CM | 1 |
Braun, LMM; De Man, RA; Dwarkasing, RS; Gest, B; Hunink, M; Ijzermans, JN; Thomeer, MG; van Koeverden, S; Vanhooymissen, IJSML; Willemssen, FE | 1 |
Brancatelli, G; Duca, P; Khouri Chalouhi, C; Rini, F; Tuscano, B; Vanzulli, A; Vernuccio, F | 1 |
Bartolotta, TV; Brancatelli, G; Lagalla, R; Matranga, D; Midiri, M; Taibbi, A | 1 |
Al Saleh, T; Baalbaki, M; Chehabeddine, L; Hannoun, S; Khoury, SJ; Saleh, E | 1 |
Fowler, KJ; Fraum, TJ; Khanna, G; Ludwig, DR; Rohe, E; Romberg, EK | 1 |
Block, TK; Boll, DT; Glessgen, CG; Heye, TJ; Merkle, EM; Moor, M; Stieltjes, B; Winkel, DJ | 1 |
Colgan, T; Knobloch, G; Reeder, SB; Schubert, T; Wang, X; Woo, KM | 1 |
Luciani, A; Reizine, E | 1 |
Hull, NC; Lee, EY; Schooler, GR | 1 |
Braun, LMM; De Man, RA; Dwarkasing, RS; Ijzermans, JN; Thomeer, MG; van Koeverden, S; Vanhooymissen, IJSML; Willemssen, FE | 1 |
Brancatelli, G; Cannella, R; Furlan, A; Gozzo, C; Greco, V; Midiri, M; Tang, A; Vernuccio, F | 1 |
Akyüz, C; Haliloğlu, M; Karçaaltıncaba, M; Oğuz, B; Özcan, HN; Seber, T; Yalçın, B | 1 |
Choi, JY; Chung, YE; Kim, MJ; Kim, SU; Kim, YY; Lee, M; Park, MS | 1 |
Bane, O; Cuevas, J; Cunha, GM; Fowler, KJ; Hectors, S; Kennedy, P; Lewis, S; Said, D; Sirlin, CB; Stocker, D; Taouli, B; Vietti-Violi, N | 1 |
Block, TK; Boll, DT; Breit, HC; Glessgen, CG; Heye, T; Merkle, EM | 1 |
Hsiao, JK; Lee, YH; Wu, MR | 1 |
Froehlich, JM; Guirguis, N; Gutzeit, A; Koh, DM; Kolokythas, O; Matoori, S; Moussa, L; Sartoretti-Schefer, S; Wu, D | 1 |
18 review(s) available for meglumine and gadoxetic acid disodium
Article | Year |
---|---|
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Safety | 1996 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
[Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].
Topics: Chelating Agents; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Practice Patterns, Physicians'; Reproducibility of Results; Sensitivity and Specificity | 2004 |
New MR techniques for the detection of liver metastases.
Topics: Adenocarcinoma; Artifacts; Colorectal Neoplasms; Contrast Media; Cysts; Equipment Design; Fatty Liver; Forecasting; Gadolinium; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2006 |
Contrast agents for hepatic MRI.
Topics: Contrast Media; Dextrans; Diagnosis, Differential; Ferrosoferric Oxide; Gadolinium DTPA; Humans; Iron; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides | 2007 |
Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron Compounds; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2008 |
High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review.
Topics: Brain; Brain Mapping; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Hemodynamics; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Models, Neurological; Neovascularization, Pathologic; Organometallic Compounds; Stroke | 2010 |
Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatocytes; Humans; Incidental Findings; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2011 |
Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents.
Topics: Contrast Media; Diagnosis, Differential; Gadolinium DTPA; Hepatocytes; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2011 |
Hepatobiliary MR imaging with gadolinium-based contrast agents.
Topics: Bile Duct Diseases; Contrast Media; Gadolinium DTPA; Humans; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2012 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2013 |
Gadolinium-Induced Fibrosis.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic | 2016 |
Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Utilization Review | 2017 |
Liver Function Assessment by Magnetic Resonance Imaging.
Topics: Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2016 |
A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine.
Topics: Contrast Media; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2017 |
Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.
Topics: Child; Contrast Media; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pattern Recognition, Automated | 2020 |
3 trial(s) available for meglumine and gadoxetic acid disodium
Article | Year |
---|---|
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Europe; Gadolinium DTPA; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.
Topics: Adult; Biliary Tract; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Signal-To-Noise Ratio; Young Adult | 2011 |
Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
Topics: Adult; Breath Holding; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Healthy Volunteers; Humans; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prospective Studies | 2017 |
58 other study(ies) available for meglumine and gadoxetic acid disodium
Article | Year |
---|---|
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.
Topics: Animals; Anion Transport Proteins; Bilirubin; Binding, Competitive; Biological Transport; Carrier Proteins; Cell Membrane; Contrast Media; Gadolinium DTPA; Humans; Kinetics; Liver; Magnetic Resonance Imaging; Meglumine; Oocytes; Organometallic Compounds; Osmolar Concentration; Rats; RNA, Messenger; Sulfobromophthalein; Taurocholic Acid; Xenopus laevis | 1999 |
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Topics: Adult; Bile Ducts; Bile Ducts, Intrahepatic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hepatic Duct, Common; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Time Factors | 2007 |
Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
Topics: Animals; Contrast Media; Female; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Meglumine; Mice; Mice, Inbred BALB C; Organometallic Compounds | 2009 |
Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Topics: Adult; Analysis of Variance; Contrast Media; Female; Gadolinium DTPA; Humans; Likelihood Functions; Liver Circulation; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 2009 |
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2009 |
Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.
Topics: Adult; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Hyperplasia; Image Processing, Computer-Assisted; Liver; Magnetic Resonance Imaging; Meglumine; Middle Aged; Time Factors | 2010 |
Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats | 2010 |
Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI.
Topics: Adult; Bile Ducts; Contrast Media; Female; Gadolinium DTPA; Hepatic Artery; Humans; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Patient Selection; Preoperative Care; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Hepatocyte-specific magnetic resonance imaging contrast agents.
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Hepatocytes; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds | 2011 |
Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.
Topics: Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Portal Vein; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Retrospective Studies; Spleen; Treatment Outcome | 2012 |
Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Topics: Contrast Media; Female; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA, and Gd-BOPTA for dynamic MR imaging of the liver in rat models.
Topics: Animals; Contrast Media; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats; Rats, Wistar | 2012 |
Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Topics: Adolescent; Adult; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2012 |
Liver-specific contrast agents.
Topics: Contrast Media; Gadolinium DTPA; Humans; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2012 |
Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Topics: Adenoma, Liver Cell; Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatic Artery; Hepatocytes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Mass Screening; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Retrospective Studies; Sensitivity and Specificity | 2013 |
Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
Topics: Adult; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2012 |
Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents--comparison of Gd-EOB-DTPA and Gd-BOPTA.
Topics: Abdomen; Abdominal Neoplasms; Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Hepatocytes; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2013 |
Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
Topics: Adipose Tissue; Adiposity; Adult; Aged; Contrast Media; Fatty Liver; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2013 |
Liver adenomatosis: serial investigation on MRI.
Topics: Adenoma; Adolescent; Adult; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Remission, Spontaneous; Retrospective Studies | 2014 |
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phenotype; Risk Factors; Tomography, X-Ray Computed | 2014 |
Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Motion; Observer Variation; Organometallic Compounds; Prospective Studies; Reproducibility of Results | 2015 |
Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Gadolinium DTPA; Hepatic Artery; Humans; Imaging, Three-Dimensional; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Respiration; Retrospective Studies; Risk Factors | 2014 |
Incidence and severity of acute adverse reactions to four different gadolinium-based MR contrast agents.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Severity of Illness Index | 2014 |
MRI of hepatic epithelioid hemangioendothelioma (HEH).
Topics: Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2014 |
The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging.
Topics: Blood Proteins; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Proteins | 2014 |
Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Motion; Organometallic Compounds; Respiration; Retrospective Studies | 2015 |
CAIPIRINHA-Dixon-TWIST (CDT)-volume-interpolated breath-hold examination (VIBE) for dynamic liver imaging: comparison of gadoterate meglumine, gadobutrol and gadoxetic acid.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Breath Holding; Contrast Media; Female; Gadolinium DTPA; Hepatic Artery; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2014 |
Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Injections; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors | 2015 |
An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging.
Topics: Adult; Aged; Artifacts; Contrast Media; Dyspnea; Female; Gadolinium DTPA; Humans; Japan; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Movement; Organometallic Compounds; Prospective Studies; United States | 2016 |
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Hepatocytes; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2015 |
Comparison of gadoxetic acid to gadobenate dimeglumine for assessment of biliary anatomy of potential liver donors.
Topics: Adult; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Transplantation; Living Donors; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2016 |
MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2016 |
Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
Topics: Artifacts; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Liver; Liver Cirrhosis; Longitudinal Studies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Motion; Organometallic Compounds; Reproducibility of Results; Respiratory Mechanics; Retrospective Studies; Sensitivity and Specificity | 2017 |
Gallbladder opacification on gadoxetate disodium-enhanced CT scan.
Topics: Adult; Cholangiopancreatography, Magnetic Resonance; Cholecystitis; Contrast Media; Female; Gadolinium DTPA; Gallbladder; Humans; Image Interpretation, Computer-Assisted; Male; Meglumine; Middle Aged; Organometallic Compounds; Tomography, X-Ray Computed | 2017 |
Removal of gadolinium-based contrast agents: adsorption on activated carbon.
Topics: Adsorption; Carbon; Contrast Media; Gadolinium DTPA; Hydrogen-Ion Concentration; Kinetics; Meglumine; Organometallic Compounds; Urine; Water Pollutants, Chemical; Water Pollution | 2017 |
Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Ascites; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Germany; Humans; Infusions, Intravenous; Liver; Liver Cirrhosis; Liver Neoplasms; Lung Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pleural Effusion; Risk Factors; Young Adult | 2017 |
Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents.
Topics: Adenoma; Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; Fatty Liver; Female; Focal Nodular Hyperplasia; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Inflammation; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2018 |
Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents.
Topics: Adult; Aged; Ascitic Fluid; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pleural Effusion; Retrospective Studies | 2018 |
Reactions to Both Nonionic Iodinated and Gadolinium-Based Contrast Media: Incidence and Clinical Characteristics.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Incidence; Iodine; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors | 2018 |
Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2018 |
Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Topics: Adenoma, Liver Cell; Adult; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reference Standards; Reproducibility of Results; Retrospective Studies; Young Adult | 2019 |
Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cross-Sectional Studies; Female; Gadolinium DTPA; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Young Adult | 2019 |
Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
Topics: Adult; Contrast Media; Evaluation Studies as Topic; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2019 |
Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
Topics: Adult; Brain; Cerebellar Nuclei; Contrast Media; Environmental Exposure; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 2019 |
Diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2017 in predicting malignant liver lesions in pediatric patients: a preliminary study.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Hemodynamics; Humans; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Movement; Organometallic Compounds; Plethysmography; Prospective Studies; Respiration Disorders; Young Adult | 2019 |
Combined gadoxetic acid and gadobenate dimeglumine enhanced liver MRI: a parameter optimization study.
Topics: Adult; Contrast Media; Feasibility Studies; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prospective Studies; Reference Values | 2020 |
Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia".
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
Response to Letter: Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of HCA From FNH.
Topics: Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?
Topics: Aged; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Liver Cirrhosis; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Portal Vein; Retrospective Studies | 2020 |
Hepatocyte-specific contrast-enhanced MRI findings of focal nodular hyperplasia-like nodules in the liver following chemotherapy in pediatric cancer patients.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Drug Therapy; Female; Focal Nodular Hyperplasia; Follow-Up Studies; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Infant; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2020 |
MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Longitudinal Studies; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Assessment | 2020 |
Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Perfusion; Prospective Studies | 2021 |
Respiratory anomalies associated with gadoxetate disodium and gadoterate meglumine: compressed sensing MRI revealing physiologic phenomena during the entire injection cycle.
Topics: Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2022 |
Organic Anion Transporting Polypeptide 1B1 Is a Potential Reporter for Dual MR and Optical Imaging.
Topics: Gadolinium DTPA; Genes, Reporter; HEK293 Cells; Humans; Liver-Specific Organic Anion Transporter 1; Magnetic Resonance Imaging; Meglumine; Molecular Imaging; Optical Imaging; Organometallic Compounds; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2021 |
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study.
Topics: Bile; Cholangiography; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine | 2023 |